Lipocine is a biopharmaceutical company that researches, develops and commercializes drugs for the treatment of metabolic and endocrine disorders.
Read moreChairman & CEO
Mahesh V. Patel
Annual Revenue
$16.1M
Lipocine's revenue is the ranked 10th among it's top 10 competitors. The top 10 competitors average 217.7M. Over the last two quarters, Lipocine's revenue has grown by 29150.2%. Specifically, in Q4 2021's revenue was $16.1M; in Q3 2021, it was $ < 1M.